title: Therapeutic approaches to patients with mucous membrane pemphigoid.
abstract: The therapeutic approach to mucous membrane pemphigoid is site specific, with the goal of preserving function for patients with chronic and treatment-resistant disease. The involvement of certain mucosal sites (ie, ocular, laryngeal, esophageal, nasopharyngeal, and anogenital) is high risk and warrants more aggressive intervention. Control of the disease must be balanced with minimizing the sequelae of long-term exposure to systemic glucocorticosteroids and/or other immunosuppressives. Timely interventions and multidisciplinary management are essential in preventing disability.
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center in Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. askderm@gmail.com
authors.forename: A Shadi
authors.initials: AS
authors.lastname: Kourosh
authors.forename: Kim B
authors.initials: KB
authors.lastname: Yancey
mesh_terms: D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012306:Risk
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents